Ciprofibrate diminishes non-hdlc and improves hdlc in patients with frederickson type iv dyslipidemia phenotype

Objective: Hypertriacylglyceridemia and low HDLc combination is one of the most common lipidic abnormalities. Thus, the aim of thisstudy was to determine the effects of Ciprofibrate on patients with Frederickson’s Type IV dyslipidemia phenotype. Research designand methods: 75 patients with type IV d...

Olles dieđut

Bibliográfalaš dieđut

Publikašuvnnas:	Archivos Venezolanos de Farmacología y Terapéutica
Váldodahkkit:	M. Cabrera de B, A. Amell de D, N. Leal de P, R. Cano-Peñaloza, G. Puche-Medina, V. Bermúdez-Pirela, A. Souki, C. Cano-Ponce, F. Bermúdez-Arias, E. Mengual-Moreno, E. Leal-Gonzalez, M. Lemus-Antepaz, I. Ramirez, F. Contreras, M. Velasco
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Sociedad Venezolana de Farmacología Clínica y Terapéutica 2005
Fáttát:	Medicina
Liŋkkat:	https://www.redalyc.org/articulo.oa?id=55924203
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!